+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vietnam Interventional Cardiology Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • February 2024
  • Region: Vietnam
  • Expert Market Research
  • ID: 5941107

Vietnam Interventional Cardiology Market Outlook

The Vietnam interventional cardiology market size was valued at USD 0.8 billion in 2023, driven by a growing preference for minimally invasive procedures among both healthcare professionals and patients. The market size is anticipated to grow at a CAGR of 7.45% during the forecast period of 2024-2032 to achieve a value of USD 1.4 billion by 2032.

Interventional Cardiology: Introduction

Interventional cardiology is a specialized area of cardiology that diagnoses and treats cardiovascular diseases using catheter-based procedures. Instead of traditional surgery, doctors insert a catheter through a small incision in the leg or arm to reach the heart and blood vessels. This approach is used for various treatments, including angioplasty (widening narrowed or blocked arteries), stent placement, and correcting certain types of heart defects. Interventional cardiology offers patients shorter recovery times and less discomfort compared to open-heart surgery.

Key Trends in the Vietnam Interventional Cardiology Market

Vietnam's interventional cardiology market is witnessing a growing preference for minimally invasive procedures among both healthcare professionals and patients. This trend is driven by the benefits of these procedures, such as shorter hospital stays, reduced recovery times, and lower risk of complications compared to traditional surgery.

The rising prevalence of cardiovascular diseases in Vietnam, attributed to changing lifestyles, increased smoking rates, and a growing elderly population, is driving demand for interventional cardiology services. This includes a higher incidence of conditions that require interventional cardiology treatments, such as coronary artery disease and heart valve disorders.

There is a notable interest in the adoption of advanced technologies within the field, including drug-eluting stents, bioresorbable stents, and cutting-edge imaging techniques. These advancements offer improved outcomes for patients and are gradually being integrated into clinical practice across Vietnam.

Increased investment from both the government and private sectors is supporting the growth of the market. Funding is being directed toward purchasing new medical devices, expanding hospital capacities, and improving the quality of medical services.

Collaborations and partnerships with international medical institutions and companies are playing a key role in the development of the interventional cardiology field. These partnerships are facilitating the transfer of knowledge, training of medical staff, and access to the latest cardiology treatments and technologies.

Vietnam is actively working on expanding and modernizing its healthcare infrastructure, including the development of specialized cardiac centers and the training of healthcare professionals in interventional cardiology. This expansion is crucial for broadening access to care, especially in underserved rural areas.

Vietnam Interventional Cardiology Market Segmentation

Market Breakup by Product

  • Catheters
  • Angiography Catheters
  • Balloon Dilatation Catheters
  • Percutaneous Transluminal Coronary Angioplasty Guiding Catheters
  • Guide Extension Catheters
  • Microcatheters
  • Dual Lumen Catheters
  • Others
  • Guide Wires
  • Coronary Guide Wires
  • Specialty Guide Wires
  • Coronary Stents
  • Bare Stents
  • Drug-Eluting Stents
  • Bio Absorbable Stents
  • Angioplasty Balloons
  • Old/Normal Balloons
  • Drug-Eluting Balloons
  • Cutting/Scoring Balloons
  • Plague Modification Devices
  • Thrombectomy Devices
  • Atherectomy
  • Hemodynamic Flow Alteration Devices
  • Embolic Protection Devices
  • Chronic Total Occlusion Devices
  • Vascular Closure Devices (VCDS)
  • Nitinol Clip-Based (Starclose) Devices
  • Suture Based (Perclose)
  • Collagen Plug-Based (Angio-Seal)
  • Fractional Flow Reserve (FFR)
  • Accessories
  • Angioplasty Kits
  • Balloon Inflation Devices
  • Introducer Sheaths
  • Hemostasis Heart
  • Others

Market Breakup by Type

  • Conventional
  • Catheters
  • Coronary Guide Wires
  • Coronary Stents
  • Vascular Closure Devices (VCDS)
  • Others
  • Advanced
  • Plague Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Intravascular Ultrasound (IVUS) Catheters
  • Fractional Flow Reserve (FFR)

Market Breakup by Indication

  • Cardiac Catheterization
  • Percutaneous Coronary Intervention (PCI)
  • Coronary Thrombectomy
  • Atherectomy
  • Balloon Angioplasty
  • Stent Implantation
  • Hypothermia/Intra-Aortic Balloon Pump
  • Patent Foramen Ovale Closure
  • Others

Market Breakup by Age

  • Adult
  • Pediatric
  • Geriatric

Market Breakup by Distribution Channel

  • Direct Tenders
  • Third Party Distributors

Market Breakup by End User

  • Hospitals
  • Acute Care Hospitals
  • Long-Term Care Hospitals
  • Cath Laboratories
  • Academic and Research Institutes

Market Breakup by Region

  • Northern and Central
  • Western
  • Southern
  • Eastern

Vietnam Interventional Cardiology Market Overview

There is a rising demand for interventional cardiology procedures in Vietnam, driven by a growing awareness of cardiovascular diseases (CVDs) and their impact. This trend is supported by the country's aging population and lifestyle changes leading to higher incidences of heart-related conditions.

The Vietnamese government is actively working to improve healthcare infrastructure and access to medical services, including advanced cardiac care. Investments in healthcare facilities, training for medical professionals, and initiatives to enhance the quality of care are key factors supporting the market's growth.

Vietnam is witnessing an adoption of advanced technologies in interventional cardiology, such as drug-eluting stents and minimally invasive surgical techniques. These advancements are improving patient outcomes and offering alternatives to traditional surgical procedures.

Vietnam Interventional Cardiology Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • Boston Scientific Corporation
  • Terumo Vietnam Medical Equipments Co., Ltd
  • Abbott Laboratories
  • Medtronic Plc
  • Stryker Corporation
  • Becton, Dickinson and Company
  • Angio Dynamics
  • B. Braun Melsungen AG
  • Biotronik
  • Medinol LTD.
  • Philips Electronics N.V.
  • Teleflex Incorporated
  • USM Healthcare
  • Edwards Lifesciences
  • Penumbra Inc


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Vietnam Interventional Cardiology Market Overview
3.1 Vietnam Interventional Cardiology Market Historical Value (2017-2023)
3.2 Vietnam Interventional Cardiology Market Forecast Value (2024-2032)
4 Vietnam Interventional Cardiology Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Vietnam Interventional Cardiology Market Segmentation
5.1 Vietnam Interventional Cardiology Market by Product
5.1.1 Market Overview
5.1.2 Catheters
5.1.2.1 Angiography Catheters
5.1.2.2 Balloon Dilatation Catheters
5.1.2.3 Percutaneous Transluminal Coronary Angioplasty Guiding Catheters
5.1.2.4 Guide Extension Catheters
5.1.2.5 Microcatheters
5.1.2.6 Dual Lumen Catheters
5.1.2.7 Others
5.1.3 Guide Wires
5.1.3.1 Coronary Guide Wires
5.1.3.2 Specialty Guide Wires
5.1.4 Coronary Stents
5.1.4.1 Bare Stents
5.1.4.2 Drug-Eluting Stents
5.1.4.3 Bio Absorbable Stents
5.1.5 Angioplasty Balloons
5.1.5.1 Old/Normal Balloons
5.1.5.2 Drug-Eluting Balloons
5.1.5.3 Cutting/Scoring Balloons
5.1.6 Plague Modification Devices
5.1.6.1 Thrombectomy Devices
5.1.6.2 Atherectomy
5.1.7 Hemodynamic Flow Alteration Devices
5.1.7.1 Embolic Protection Devices
5.1.7.2 Chronic Total Occlusion Devices
5.1.8 Vascular Closure Devices (VCDS)
5.1.9 Nitinol Clip-Based (Starclose) Devices
5.1.10 Suture Based (Perclose)
5.1.11 Collagen Plug-Based (Angio-Seal)
5.1.12 Fractional Flow Reserve (FFR)
5.1.13 Accessories
5.1.14 Angioplasty Kits
5.1.15 Balloon Inflation Devices
5.1.16 Introducer Sheaths
5.1.17 Hemostasis Heart
5.1.18 Others
5.2 Vietnam Interventional Cardiology Market by Type
5.2.1 Market Overview
5.2.2 Conventional
5.2.2.1 Catheters
5.2.2.2 Coronary Guide Wires
5.2.2.3 Coronary Stents
5.2.2.4 Vascular Closure Devices (VCDS)
5.2.2.5 Others
5.2.3 Advanced
5.2.3.1 Plague Modification Devices
5.2.3.2 Hemodynamic Flow Alteration Devices
5.2.3.3 Intravascular Ultrasound (IVUS) Catheters
5.2.3.4 Fractional Flow Reserve (FFR)
5.3 Vietnam Interventional Cardiology Market by Indication
5.3.1 Market Overview
5.3.2 Cardiac Catheterization
5.3.3 Percutaneous Coronary Intervention (PCI)
5.3.4 Coronary Thrombectomy
5.3.5 Atherectomy
5.3.6 Balloon Angioplasty
5.3.7 Stent Implantation
5.3.8 Hypothermia/Intra-Aortic Balloon Pump
5.3.9 Patent Foramen Ovale Closure
5.3.10 Others
5.4 Vietnam Interventional Cardiology Market by Age
5.4.1 Market Overview
5.4.2 Adult
5.4.3 Pediatric
5.4.4 Geriatric
5.5 Vietnam Interventional Cardiology Market by Distribution Channel
5.5.1 Market Overview
5.5.2 Direct Tenders
5.5.3 Third Party Distributors
5.6 Vietnam Interventional Cardiology Market by End User
5.6.1 Market Overview
5.6.2 Hospitals
5.6.2.1 Acute Care Hospitals
5.6.2.2 Long-Term Care Hospitals
5.6.3 Cath Laboratories
5.6.4 Academic & Research Institutes
5.6.5 Other
5.7 Vietnam Interventional Cardiology Market by Region
5.7.1 Market Overview
5.7.2 Northern and Central
5.7.3 Western
5.7.4 Southern
5.7.5 Eastern
6 Patent Analysis
6.1 Analysis by Type of Patent
6.2 Analysis by Publication year
6.3 Analysis by Issuing Authority
6.4 Analysis by Patent Age
6.5 Analysis by CPC Analysis
6.6 Analysis by Patent Valuation
6.7 Analysis by Key Players
7 Grants Analysis
7.1 Analysis by year
7.2 Analysis by Amount Awarded
7.3 Analysis by Issuing Authority
7.4 Analysis by Grant Application
7.5 Analysis by Funding Institute
7.6 Analysis by NIH Departments
7.7 Analysis by Recipient Organization
8 Funding Analysis
8.1 Analysis by Funding Instances
8.2 Analysis by Type of Funding
8.3 Analysis by Funding Amount
8.4 Analysis by Leading Players
8.5 Analysis by Leading Investors
8.6 Analysis by Geography
9 Partnership and Collaborations Analysis
9.1 Analysis by Partnership Instances
9.2 Analysis by Type of Partnership
9.3 Analysis by Leading Players
9.4 Analysis by Geography
10 Regulatory Framework
11 Supplier Landscape
11.1 Boston Scientific Corporation
11.1.1 Financial Analysis
11.1.2 Product Portfolio
11.1.3 Demographic Reach and Achievements
11.1.4 Mergers and Acquisitions
11.1.5 Certifications
11.2 Terumo Vietnam Medical Equipments Co., Ltd
11.2.1 Financial Analysis
11.2.2 Product Portfolio
11.2.3 Demographic Reach and Achievements
11.2.4 Mergers and Acquisitions
11.2.5 Certifications
11.3 Abbott Laboratories
11.3.1 Financial Analysis
11.3.2 Product Portfolio
11.3.3 Demographic Reach and Achievements
11.3.4 Mergers and Acquisitions
11.3.5 Certifications
11.4 Medtronic Plc
11.4.1 Financial Analysis
11.4.2 Financial Portfolio
11.4.3 Demographic Reach and Achievements
11.4.4 Mergers and Acquisitions
11.4.5 Certifications
11.5 Stryker Corporation
11.5.1 Financial Analysis
11.5.2 Product Portfolio
11.5.3 Demographic Reach and Achievements
11.5.4 Mergers and Acquisitions
11.5.5 Certifications
11.6 Becton, Dickinson and Company
11.6.1 Financial Analysis
11.6.2 Product Portfolio
11.6.3 Demographic Reach and Achievements
11.6.4 Mergers and Acquisitions
11.6.5 Certifications
11.7 Angio Dynamics
11.7.1 Financial Analysis
11.7.2 Product Portfolio
11.7.3 Demographic Reach and Achievements
11.7.4 Mergers and Acquisitions
11.7.5 Certifications
11.8 B. Braun Melsungen AG
11.8.1 Financial Analysis
11.8.2 Product Portfolio
11.8.3 Demographic Reach and Achievements
11.8.4 Mergers and Acquisitions
11.8.5 Certifications
11.9 Biotronik
11.9.1 Financial Analysis
11.9.2 Product Portfolio
11.9.3 Demographic Reach and Achievements
11.9.4 Mergers and Acquisitions
11.9.5 Certifications
11.10 Medinol LTD.
11.10.1 Financial Analysis
11.10.2 Product Portfolio
11.10.3 Demographic Reach and Achievements
11.10.4 Mergers and Acquisitions
11.10.5 Certifications
11.11 Philips Electronics N.V.
11.11.1 Financial Analysis
11.11.2 Product Portfolio
11.11.3 Demographic Reach and Achievements
11.11.4 Mergers and Acquisitions
11.11.5 Certifications
11.12 Teleflex Incorporated
11.12.1 Financial Analysis
11.12.2 Product Portfolio
11.12.3 Demographic Reach and Achievements
11.12.4 Mergers and Acquisitions
11.12.5 Certifications
11.13 USM Healthcare
11.13.1 Financial Analysis
11.13.2 Product Portfolio
11.13.3 Demographic Reach and Achievements
11.13.4 Mergers and Acquisitions
11.13.5 Certifications
11.14 Edwards Lifesciences
11.14.1 Financial Analysis
11.14.2 Product Portfolio
11.14.3 Demographic Reach and Achievements
11.14.4 Mergers and Acquisitions
11.14.5 Certifications
11.15 Penumbra Inc
11.15.1 Financial Analysis
11.15.2 Product Portfolio
11.15.3 Demographic Reach and Achievements
11.15.4 Mergers and Acquisitions
11.15.5 Certifications
12 Vietnam Interventional Cardiology Market - Distribution Model (Additional Insight)
12.1 Overview
12.2 Potential Distributors
12.3 Key Parameters for Distribution Partner Assessment
13 Key Opinion Leaders (KOL) Insights (Additional Insight)
14 Company Competitiveness Analysis (Additional Insight)
14.1 Very Small Companies
14.2 Small Companies
14.3 Mid-Sized Companies
14.4 Large Companies
14.5 Very Large Companies
15 Payment Methods (Additional Insight)
15.1 Government Funded
15.2 Private Insurance
15.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • Boston Scientific Corporation
  • Terumo Vietnam Medical Equipments Co. Ltd
  • Abbott Laboratories
  • Medtronic Plc
  • Stryker Corporation
  • Becton
  • Dickinson and Company
  • Angio Dynamics
  • B. Braun Melsungen AG
  • Biotronik
  • Medinol LTD.
  • Philips Electronics N.V.
  • Teleflex Incorporated
  • USM Healthcare
  • Edwards Lifesciences
  • Penumbra Inc

Methodology

Loading
LOADING...

Table Information